1. Estrogen Receptor β Expression and Its Clinical Implication in Breast Cancers: Favorable or Unfavorable?
   Young Choi, 2022, Journal of Breast Cancer CrossRef
2. The heterogeneous subclones might be induced by cycling hypoxia which was aggravated along with the luminal A tumor growth
   Yue Kang et al, 2022, Tissue and Cell CrossRef
3. ERβ Isoforms Have Differential Clinical Significance in Breast Cancer Subtypes and Subgroups
   Young Choi et al, 2022, Current Issues in Molecular Biology CrossRef
4. Jagged1 promotes aromatase inhibitor resistance by modulating tumor-associated macrophage differentiation in breast cancer patients
   Hang Liu et al, 2017, Breast Cancer Research and Treatment CrossRef
5. Association of the Estrogen Receptors Beta Expression with the Ki-67 Proliferative Index in Breast Cancer
   T. A. Bogush et al, 2023, Antibiotics and Chemotherapy CrossRef
6. Exploring new pathways in endocrine-resistant breast cancer
   Inês Soares de Pinho et al, 2022, Exploration of Targeted Anti-tumor Therapy CrossRef
7. The role of estrogen receptor beta in breast cancer
   Yujing Zhou et al, 2020, Biomarker Research CrossRef
8. Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors
   Hina Dalal et al, 2022, Scientific Reports CrossRef
9. TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer
   Utpal K Mukhopadhyay et al, 2019, JNCI: Journal of the National Cancer Institute CrossRef
10. Hormone receptor expression in aging mammary tissue and carcinoma from a rodent model after xenoestrogen disruption
    Thalles Fernando Rocha Ruiz et al, 2021, Life Sciences CrossRef
11. Anticancer or carcinogenic? The role of estrogen receptor β in breast cancer progression
    Kang Shen et al, 2023, Pharmacology & Therapeutics CrossRef